IPO Guru
Bajaj
Listed Mainboard

Eris Lifesciences IPO Subscription Status

Eris Lifesciences IPO was subscribed 3.29 times when bidding closed on 20 Jun 2017: QIB 4.68x, NII 0.45x, Retail 3.51x.

The Eris Lifesciences IPO has been subscribed 3.29x times overall. Retail investors have shown interest with bids for 3.51x the shares available. The Non-Institutional Investor (NII) category has been subscribed 0.45x. Qualified Institutional Buyers (QIBs) have subscribed 4.68x. Data last updated on 12 Nov, 03:11 PM.

The IPO subscription period has ended. The issue opened on 16 Jun, 2017 and closes on 20 Jun, 2017. The shares are expected to list on stock exchanges on 29 Jun, 2017.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 12 Nov 2026, 03:11 PM
Category Bid details Times
QIB - of - - 4.68x
NII - of - - 0.45x
Retail - of - - 3.51x
Employee - of - - 0.86x
TOTAL - - 3.29x
Advertisement

Eris Lifesciences IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
2 out of 7
~28.5% chance per PAN — based on 3.51x subscription. Winners get exactly 1 lot (₹14,472) by SEBI lottery, however many lots you bid.
NII / HNI (above ₹2 L)
Full allotment
0.45x — undersubscribed.
QIB (institutions)
4.68x
Proportionate allotment — at 4.68x, institutions receive ~21.4% of their bid. No lottery; not open to individual investors. Moderate institutional demand.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 28.5% for a single lot.

Day-wise subscription history

End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.

Date Total
20 Jun 2017
Day 3
3.29x ▼
QIB4.68x BHNI- SHNI- Retail3.51x Employee0.86x
19 Jun 2017
Day 2
0.75x ▼
QIB- BHNI- SHNI- Retail-
16 Jun 2017
Day 1
0.12x ▼
QIB- BHNI- SHNI- Retail-

Eris Lifesciences IPO dates

From the bidding window to listing. Today is 14 November.

Key dates Listed
  1. Open 16 Jun 2017
  2. Close 20 Jun 2017
  3. Allotment 23 Jun 2017
  4. Refund/credit 27 Jun 2017
  5. Listing 29 Jun 2017

Anchor investor allocation

Shares allotted to anchor investors the working day before the issue opened.

Anchor Investor Amt (₹ cr.) % Allocated
ABU DHABI INVESTMENT AUTHORITY - BEHAVE ₹71.00 Cr 9.11%
GOLDMAN SACHS INDIA LIMITED ₹64.26 Cr 8.24%
FIL INVESTMENTS (MAURITIUS) LIMITED ₹60.00 Cr 7.70%
MERRILL LYNCH MARKETS SINGAPORE PTE LTD ₹60.00 Cr 7.70%
IDFC PREMIER EQUITY FUND ₹50.00 Cr 6.41%
MOTILAL OSWAL MOST FOCUSED MULTICAP 35 FUND ₹47.45 Cr 6.09%
MORGAN STANLEY INDIA INVESTMENT FUND INC ₹35.63 Cr 4.57%
MORGAN STANLEY INVESTMENT FUNDS INDIAN EQUITY FUND ₹35.37 Cr 4.54%
SBI MAGNUM BALANCED FUND ₹30.00 Cr 3.85%
SBI MAGNUM MIDCAP FUND ₹30.00 Cr 3.85%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE BALANCED 95 FUND ₹26.00 Cr 3.34%
THE MASTER TRUST BANK OF JAPAN LTD. AS TRUSTEE OF BLACKROCK INDIA EQUITY FUND ₹24.70 Cr 3.17%
FOREFRONT ALTERNATIVE EQUITY SCHEME ₹24.57 Cr 3.15%
SBI LIFE INSURANCE COMPANY ₹24.57 Cr 3.15%
TATA AIA LIFE INSUARNCE CO LTD - WHOLE LIFE MID CAP EQUITY FUND- ULIF00 04/01/07 WLE 110 ₹20.00 Cr 2.57%
DSP BLACKROCK EQUITY SAVINGS FUND ₹18.87 Cr 2.42%
DSP BLACKROCK ALTERNATIVE INVESTMENT FUND - CATEGORY III DSP BLACKROCK INDIA ENHANCED EQUITY FUND ₹17.71 Cr 2.27%
TATA TRUSTEE CO. LTD. A/C. TATA MUTUAL FUND - TATA INDIA TAX SAVINGS FUND ₹14.00 Cr 1.80%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE ADVANTAGE FUND ₹14.00 Cr 1.80%
KOTAK MAHINDRA BALANCE UNIT SCHEME 99 ₹13.80 Cr 1.77%
SBI PHARMA FUND ₹11.00 Cr 1.41%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE MANUFACTURING EQUITY FUND ₹10.00 Cr 1.28%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE MIDCAP FUND ₹10.00 Cr 1.28%
TATA MID CAP GROWTH FUND ₹9.77 Cr 1.25%
MOTILAL OSWAL MOST FOCUSED MIDCAP 30 FUND ₹9.11 Cr 1.17%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C INDIA ADVANTAGE (OFFSHORE) FUND ₹7.00 Cr 0.90%
DSP BLACKROCK MIP FUND ₹6.80 Cr 0.87%
GREATER INDIA PORTFOLIO ₹6.74 Cr 0.86%
IDFC TAX ADVANTAGE ELSS FUND ₹6.00 Cr 0.77%
INTEGRATED CORE STRATEGIES ASIA PTE LTD ₹5.06 Cr 0.65%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE INDIA GENNEXT FUND ₹4.00 Cr 0.51%
IDFC FOCUSED EQUITY FUND ₹4.00 Cr 0.51%
MOTILAL OSWAL MOST FOCUSED LONG TERM FUND ₹3.44 Cr 0.44%
DSP BLACKROCK INDIA ENHANCED EQUITY SATCORE FUND - NON LONG TERM ₹2.29 Cr 0.29%
KOTAK MONTHLY INCOME PLAN ₹1.20 Cr 0.15%
TATA INDIA PHARMA & HEALTHCARE FUND ₹0.80 Cr 0.10%
DSP BLACKROCK DUAL ADVANTAGE FUND SERIES 39-36M ₹0.33 Cr 0.04%
TOTAL ₹779.47 Cr 99.98%
View allotment letter PDF →

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Eris Lifesciences IPO?

As of IPO close date (20 Jun, 2017), the Eris Lifesciences IPO is subscribed 3.29x times. Retail category is 3.51x, and NII is 0.45x subscribed.

When is the allotment date for Eris Lifesciences IPO?

The allotment for Eris Lifesciences IPO is expected to be finalized on 23 June, 2017.

What is the GMP of Eris Lifesciences?

The Grey Market Premium (GMP) for Eris Lifesciences is currently ₹9, indicating a potential listing gain of 1%.

When will Eris Lifesciences IPO list on the stock market?

Eris Lifesciences is scheduled to list on BSE and NSE on 29 June, 2017.

What are the chances of getting allotment in Eris Lifesciences IPO?

The retail category is oversubscribed at 3.51x, meaning allotment is by lottery. Statistically, approximately 1 in 4 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 4.68x mean for Eris Lifesciences IPO?

Moderate — QIBs have subscribed 4.68x. Institutional demand is present but not overwhelming. Watch for any last-minute QIB surge on the final day.

How to check Eris Lifesciences IPO allotment status?

After the allotment date (23 Jun, 2017), you can check your Eris Lifesciences IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Eris Lifesciences IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
3.29x
QIB
4.68x
NII
0.45x
Retail
3.51x
Full IPO details
Advertisement